MEDIWOUND LTD (MDWD) Forecast, Price Target & Analyst Ratings

NASDAQ:MDWDIL0011316309

Current stock price

15.2 USD
+0.15 (+1%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDIWOUND LTD (MDWD).

Forecast Snapshot

Consensus Price Target

Price Target
$30.40
+ 99.97% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 19, 2026
Period
Q1 / 2026
EPS Estimate
-$0.67
Revenue Estimate
3.669M

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$30.40
Upside
+ 99.97%
From current price of $15.20 to mean target of $30.40, Based on 12 analyst forecasts
Low
$25.25
Median
$30.60
High
$37.80

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for MDWD. The average price target is 30.4 USD. This implies a price increase of 99.97% is expected in the next year compared to the current price of 15.2.

Analyst Ratings & History

Current Analyst Ratings

MDWD Current Analyst RatingMDWD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

MDWD Historical Analyst RatingsMDWD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
MDWD was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MDWD.
In the previous month the buy percentage consensus was at a similar level.
MDWD was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-21HC Wainwright & Co.Maintains Buy -> Buy
2025-05-22HC Wainwright & Co.Maintains Buy -> Buy
2025-03-20HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-28Craig-HallumInitiate Buy
2025-01-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-27HC Wainwright & Co.Maintains Buy -> Buy
2024-10-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-16HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-22HC Wainwright & Co.Reiterate Buy -> Buy
2024-01-16HC Wainwright & Co.Maintains Buy -> Buy
2023-11-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-21HC Wainwright & Co.Maintains Buy -> Buy
2023-08-17OppenheimerMaintains Outperform -> Outperform
2023-08-17HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-31OppenheimerReiterate Outperform -> Outperform
2023-05-31HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-17HC Wainwright & Co.Reiterate Buy
2023-01-04HC Wainwright & Co.Maintains Buy
2022-12-30Cowen & Co.Maintains Outperform
2022-12-22Maxim GroupInitiate Buy
2022-12-21OppenheimerMaintains Outperform
2022-11-16HC Wainwright & Co.Maintains Buy
2022-05-18Wells FargoMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 19, 2026
Period
Q1 / 2026
EPS Estimate
-$0.67
Revenue Estimate
3.669M
Revenue Q2Q
-7.23%
EPS Q2Q
-854.43%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-41.52%
Revenue (3 Months)
-42.68%
EPS (1 Month)
-7.38%
EPS (3 Months)
-9.62%

Next Earnings Summary

MDWD is expected to report earnings on 5/19/2026. The consensus EPS estimate for the next earnings is -0.67 USD and the consensus revenue estimate is 3.67M USD.
The next earnings revenue estimate has been revised downward by 42.68% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MDWD revenue by date.MDWD revenue by date.
18.686M
-29.49%
20.222M
8.22%
16.959M
-16.14%
25.248M
48.88%
34.105M
35.08%
54.658M
60.26%
109.19M
99.77%
180.92M
65.69%
211.87M
17.11%
271.85M
28.31%
379.49M
39.60%
EBITDA
YoY % growth
MDWD ebitda by date.MDWD ebitda by date.
-14.198M
-129.37%
-17.917M
-26.19%
-23.406M
-30.64%
-29.301M
-25.18%
-36.26M
-23.75%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
MDWD ebit by date.MDWD ebit by date.
-15.501M
-107.79%
-19.4M
-25.15%
-25.266M
-30.24%
-34.895M
-38.11%
-28.24M
19.07%
-19.034M
32.60%
11.683M
161.38%
51.75M
342.95%
72.033M
39.19%
116.45M
61.66%
187.06M
60.64%
Operating Margin
MDWD operating margin by date.MDWD operating margin by date.
-82.96%-95.94%-148.98%-138.21%-82.80%-34.82%10.70%28.60%34.00%42.84%49.29%
EPS
YoY % growth
MDWD eps by date.MDWD eps by date.
-0.77
79.58%
-3.07
-298.70%
-2.10
31.60%
-2.47
-17.46%
-2.24
9.36%
-1.93
13.78%
0.65
133.86%
2.41
269.53%
4.56
89.01%
6.78
48.77%
N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.67
-854.43%
-0.72
41.40%
-0.72
-201.04%
-0.69
-23.86%
-0.52
22.14%
-0.53
25.94%
-0.53
26.12%
-0.51
26.47%
Revenue
Q2Q % growth
3.669M
-7.23%
5.225M
-8.46%
7.531M
38.72%
9.298M
398.02%
7.85M
113.95%
8.169M
56.34%
8.772M
16.48%
9.273M
-0.27%
EBITDA
Q2Q % growth
-7.962M
-63.59%
-8.701M
-75.27%
-9.035M
-68.72%
-8.693M
-46.35%
-7.3M
8.31%
-7.548M
13.25%
-7.625M
15.61%
-7.008M
19.39%
EBIT
Q2Q % growth
-8.355M
-59.90%
-9.052M
-58.37%
-9.385M
-43.83%
-9.366M
-20.07%
-7.327M
12.30%
-7.616M
15.87%
-7.65M
18.49%
-7.356M
21.46%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MDWD Yearly Revenue VS EstimatesMDWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
MDWD Yearly EPS VS EstimatesMDWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
2.66%
EPS Next 5 Year
25.78%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
36.20%
Revenue Next 5 Year
52.93%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

MEDIWOUND LTD / MDWD Forecast FAQ

What is the price target for MDWD stock?

12 analysts have analysed MDWD and the average price target is 30.4 USD. This implies a price increase of 99.97% is expected in the next year compared to the current price of 15.2.

What is the next earnings date for MDWD stock?

MEDIWOUND LTD (MDWD) will report earnings on 2026-05-19.

What are the consensus estimates for MDWD stock next earnings?

The consensus EPS estimate for the next earnings of MEDIWOUND LTD (MDWD) is -0.67 USD and the consensus revenue estimate is 3.67M USD.

How many analysts cover MEDIWOUND LTD (MDWD) stock?

The number of analysts covering MEDIWOUND LTD (MDWD) is 12.